Harbin Three Happiness Bioengineering ("3H"), a wholly owned subsidiary of AOBO, is the manufacturer of CWJ Tablet, which is formulated entirely with pure natural ingredients and herbs.
Tony Liu, Chairman and CEO of AOBO, commented, "We are honored to receive the approval for sales of additional two TCMs in Hong Kong.
Tony Liu, Chairman and CEO of AOBO
, commented, "As the disposable income increases in China, the demand for health supplements has also risen rapidly.
AOBO entered into a letter of intent with HQPL on May 1, 2005 to record AOBO's intention to acquire HQPL.
Tony (Shujun) Liu, Chief Executive Officer of AOBO, said, "AOBO's acquisition of HQPL will enable AOBO to penetrate the wholesale and retail pharmaceutical market.
Wang commented: "Accepting the position as an AOBO
director is exciting.
has agreed to register the resale of the shares of common stock issued to the investors in this private placement, as well as the shares issuable upon exercise of the warrants.
Our extensive network of more than 2,000 sales and marketing professionals, in tandem with our R&D efforts and robust product pipeline, allows AOBO
to drive growth from new product sales.
AOBO appointed Min Jun, vice president and director of AOBO, as general manager of HSPL to oversee production, finance, technology, and sales and marketing of the acquired enterprise.
AOBO acquired 100 percent equity ownership of HSPL including all manufacturing assets, facilities, equipment, land and land use rights, raw materials, inventories, intellectual properties and technical talents on September 9, 2004.
With HSPL as part of the AOBO
, we expect a very strong and profitable second half.
the Company" or "AOBO
"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China, announced today that the Audit Committee of the Board of Directors of AOBO
approved the engagement of Ernst & Young Hua Ming ("EY") as the Company's independent registered public accounting firm for the year ending December 31, 2009.